Clinical Trials · NCT01430104

A Study of Teriparatide in Japanese Osteoporosis Patients

CompletedPhase 4Teriparatide (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
Eli Lilly and Company
Enrollment
30
Start date
Aug 2011
Locations
1 site, Japan
Primary endpoint
Number of Participants With Serum Calcium Level Over 11.0 Milligrams Per Deciliter (mg/dL)
View Teriparatide compound reference